Medicare Enrolled

Dr. Olga Brusil, M.D.

Neurology · Glenview, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1247 MILWAUKEE AVE, Glenview, IL 60025
8472962193
In practice since 2006 (19 years)
NPI: 1730275223 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Brusil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brusil? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Brusil

Dr. Olga Brusil is a neurology specialist in Glenview, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Brusil performed 621 Medicare services across 450 unique beneficiaries.

Between the years covered by Open Payments, Dr. Brusil received a total of $5,488 from 60 pharmaceutical and/or device companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Brusil is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 41% volume in IL $5,488 industry payments

Medicare Practice Summary

Medicare Utilization ↗
621
Medicare services
Top 41% in IL for neurology
450
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~33 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
268 $79 $286
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
95 $130 $316
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
66 $91 $238
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
59 $168 $503
New patient office visit, complex (60-74 min) 54 $171 $450
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
53 $139 $416
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
14 $63 $175
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
12 $26 $97
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,488
Total received (2018-2024)
Avg $915/year across 6 years
Top 30% in IL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
250
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,488 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$911
2023
$1,395
2022
$1,619
2021
$1,012
2020
$93
2018
$458

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ARGENX US, INC.
$99
SK Life Science, Inc.
$87
PFIZER INC.
$73
Amneal Pharmaceuticals LLC
$70
Alexion Pharmaceuticals, Inc.
$65
Novartis Pharmaceuticals Corporation
$62
Neurocrine Biosciences, Inc.
$62
ABBVIE INC.
$49
Averitas Pharma Inc.
$48
UCB, Inc.
$37
Kyowa Kirin, Inc.
$30
Boston Scientific Corporation
$30
Takeda Pharmaceuticals U.S.A., Inc.
$30
Grifols USA, LLC
$27
ACADIA Pharmaceuticals Inc
$26
GE HEALTHCARE
$22
Inspire Medical Systems, Inc.
$22
Biogen, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$18
Teva Pharmaceuticals USA, Inc.
$18
InSightec,Inc
$16
Top 3 companies account for 28.4% of 2024 payments
All-time payments by company (2018-2024) ›
ARGENX US, INC.
$488
Alexion Pharmaceuticals, Inc.
$382
Biogen, Inc.
$374
AbbVie Inc.
$358
ABBVIE INC.
$282
UCB, Inc.
$279
Amneal Pharmaceuticals LLC
$224
Neurocrine Biosciences, Inc.
$215
Teva Pharmaceuticals USA, Inc.
$206
Novartis Pharmaceuticals Corporation
$177
SK Life Science, Inc.
$165
PFIZER INC.
$162
Mitsubishi Tanabe Pharma America, Inc.
$126
Amgen Inc.
$121
Biohaven Pharmaceutical Holding Company Ltd.
$106
Lundbeck LLC
$98
Boston Scientific Corporation
$90
Biohaven Pharmaceuticals, Inc.
$84
Avion Pharmaceuticals
$81
Medtronic, Inc.
$81
Corium, LLC
$72
Kyowa Kirin, Inc.
$70
Abbott Laboratories
$67
Averitas Pharma Inc.
$64
CSL Behring
$62
Lilly USA, LLC
$61
Supernus Pharmaceuticals, Inc.
$61
Takeda Pharmaceuticals U.S.A., Inc.
$55
GE HealthCare
$51
Grifols USA, LLC
$48
Collegium Pharmaceutical, Inc.
$46
Allergan, Inc.
$45
GE HEALTHCARE
$43
Banner Life Sciences, LLC
$43
MITSUBISHI TANABE PHARMA AMERICA, INC.
$42
GRT US Holding, Inc.
$40
Otsuka America Pharmaceutical, Inc.
$39
ARBOR PHARMACEUTICALS, INC.
$38
Celgene Corporation
$32
Catalyst Pharmaceuticals, Inc.
$28
Alnylam Pharmaceuticals Inc.
$28
ACADIA Pharmaceuticals Inc
$26
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$25
Axsome Therapeutics, Inc.
$23
CATALYST PHARMACEUTICALS, INC.
$22
BANNER LIFE SCIENCES, LLC
$22
Inspire Medical Systems, Inc.
$22
UPSHER-SMITH LABORATORIES LLC
$20
LivaNova USA, Inc.
$20
Eisai Inc.
$20
SCILEX PHARMACEUTICALS INC.
$18
Janssen Pharmaceuticals, Inc
$18
InSightec,Inc
$16
AQUESTIVE THERAPEUTICS, INC.
$16
Strongbridge US INC.
$15
IMPEL PHARMACEUTICALS INC.
$15
Upsher-Smith Laboratories LLC
$15
EMD Serono, Inc.
$14
Novo Nordisk Inc
$14
Bayer HealthCare Pharmaceuticals Inc.
$11
Top 3 companies account for 22.7% of all-time payments
Associated products mentioned in payments ›
ACTIVA PC · ADLARITY · ADUHELM · AJOVY · AUSTEDO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · Banzel · Betaseron · Briviact · DUOPA · Dhivy · ELYXYB - celecoxib · EMGALITY · Enbrel · Exablate · FIRDAPSE · Gamunex-C · HYQVIA · Hizentra · Horizant · INFINITY · INGREZZA · INSPIRE · KESIMPTA · KEVEYIS · LYRICA · MAYZENT · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · ONGENTYS · ONPATTRO · Ongentys · Ponvory · QULIPTA · QUTENZA · Qutenza · RADICAVA · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SYMPAZAN · Soliris · Spinraza · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · UCERIS TABLETS · ULTOMIRIS · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Victoza · Vimpat · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Glenview?
Compare neurologists in the Glenview area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
593
Per 100K population
11.4
County median income
$81,797
Nearest hospital
CHICAGO BEHAVIORAL HOSPITAL
4.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Brusil is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Brusil experienced with electromyography of arm or leg muscles?
Based on Medicare claims data, Dr. Brusil performed 268 electromyography of arm or leg muscles services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brusil receive payments from pharmaceutical companies?
Yes. Dr. Brusil received a total of $5,488 from 60 companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brusil's costs compare to other neurologists in Glenview?
Dr. Brusil's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brusil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →